Purchase Order W911S223P0128
- Not listed
- This is a federal contract award to Biospace, Inc. (doing business as Inbody), a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit organization based in California. The contract, valued at $17,752.50, is a delivery order for the IN-BODY 770 BODY COMPOSITION SET. The contract has no set-aside designation and is awarded by the Department of the Army, with an ultimate completion date of October 30, 2024. Biospace, Inc. is a global leader in health technology specializing in...
- This is a federal contract award to Biospace, Inc., doing business as Inbody, for the delivery of InBody composition analyzers and related medical equipment and supplies. The $80,358.70 firm fixed-price contract was awarded by the Department of the Army and is classified under the Medical Equipment and Supplies Federal Supply Schedule 65 II A. The award has no set-aside designation. Biospace, a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit organization, has previously...
- This federal contract award is for the provision of Body Composition Analyzer (BCA) equipment to the U.S. Army. The contract, valued at $16,637.07, was awarded to Biospace, Inc., a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit organization based in Artesia, California. The contract is a purchase order with a firm fixed price, and is set aside for a small business. Biospace, Inc. is a global leader in health technology, offering award-winning body composition analyzers...
- The Department of the Army Special Operations Command awarded a $128,573.92 firm fixed-price purchase order to Biospace, Inc., a foreign-owned, minority-owned, and Asian-Pacific American-owned business, for the delivery of body fat analyzers. This award was not set aside for any specific business category. Biospace, Inc. has held multiple federal contract vehicles to provide medical equipment and supplies, including a $750,000 Federal Supply Schedule contract for body composition analyzers and a...
- This is a federal contract award by the U.S. Department of Defense's Pacific Air Forces organization to Biospace, Inc., doing business as Inbody, a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit company based in Cerritos, California. The $43,825.87 firm fixed-price delivery order contract is for the provision of medical imaging equipment and supplies, specifically body composition analyzers and related medical devices. The contract has a period of performance through...
- This federal contract award to Biospace, Inc. (doing business as Inbody) is for the provision of InBody bioelectrical impedance analysis (BIA) machines and extended warranties. The $992,316.86 firm fixed-price delivery order was issued by the U.S. Marine Corps and has an ultimate completion date of November 1, 2024. Biospace, a foreign-owned, minority-owned, Asian-Pacific American-owned for-profit organization, is the prime contractor on this contract. There is no set-aside designation...
- Biospace, Inc., doing business as Inbody, received a $23,000 firm fixed price delivery order from the Navy Expeditionary Combat Command for the InBody 970 Package. The award, issued on June 2, 2025, is set to be completed by July 5, 2025, with performance at Fort Story, Virginia. This delivery order is issued under Biospace's existing $750,000 Indefinite-Delivery/Indefinite-Quantity contract established through the General Services Administration's Medical Equipment and Supplies Federal Supply...
- This federal contract award was issued by the Federal Acquisition Service, a civilian agency, to Biospace, Inc., a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit organization. The $16,152.50 fixed-price delivery order falls under the Multiple Award Schedule (MAS) contract vehicle and is for the provision of the InBody 770 body composition analyzer. Biospace, Inc. has previously served as both a prime and subcontractor on various contracts with military and civilian...
- This is a $12,790.94 firm fixed-price delivery order awarded to Biospace, Inc. (doing business as Inbody) by the Air Force Materiel Command, a defense agency. The contract is for the supply of medical and surgical instruments, equipment, and supplies, with a period of performance running through September 30, 2023. Biospace, a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit organization, has a history of providing body composition analyzers, bioelectrical impedance...
- This firm-fixed-price delivery order, awarded by the Air Forces Europe and Africa to Biospace, Inc. (doing business as Inbody), provides $18,010.50 for the delivery of Inbody body composition analyzers. The award has an ultimate completion date of September 30, 2025. Biospace, Inc. is a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit organization that specializes in health technology and body composition analysis. This contract is not set-aside. Biospace, Inc. holds...
This federal contract award, W911S223P0128, was issued by the Department of the Army to the small business prime contractor Biospace, Inc., doing business as Inbody. The $99,822.42 firm-fixed-price purchase order is for the delivery of bioelectrical impedance body composition analyzers, under a total small business set-aside. Biospace is a foreign-owned, minority-owned, Asian-Pacific American-owned, for-profit organization based in Artesia, California. The company has a history of providing body composition analyzers, bioelectrical impedance analysis services, and related medical equipment and supplies to various military and civilian agencies, including through federal contract vehicles such as the GSA Multiple Award Schedule and the Medical Equipment and Supplies Federal Supply Schedule. Notable past contracts include a $2.3 million award from the Army Materiel Command for 145 InBody 770 analyzers and a $4.6 million award from the Marine Corps for bioelectrical impedance analysis services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $99.8k | 1/17/23 |